- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 31, 2025 | 27.38M sh |
| Stockholders Equity | FY 2024 · Dec 31, 2024 | $4.3M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | $945.97K |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $1.71M |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 26.11M sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$2.58M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $350.57K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $1.32M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $1.34M |
| Current Assets | FY 2024 · Dec 31, 2023 | $394.46K |
| Total Assets | FY 2024 · Dec 31, 2023 | $2.28M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$0.16 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$0.16 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $1.71M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $1.13M |
| Net Income | FY 2024 · Dec 31, 2023 | −$4.3M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$4.29M |